Skip to Main Content

Paper Details

A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.
Cancer Chemother Pharmacol
3
2018
Author NameAffiliation
Ho Min KimRinku General Medical Center
  • 1 - 1

Datasets

Release 1.2